C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/713 (2006.01) A61K 48/00 (2006.01) A61P 9/10 (2006.01) A61P 41/00 (2006.01) C12N 9/00 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2385228
The invention relates to a catalytically active RNA molecule that is directed to mRNA molecules that encode the cell cycle relevant proteins cyclin E or E2F1. The catalytically active RNA molecule is a hammerhead ribozyme that induces the inhibition of the cell cycle of vascular smooth muscle cells in order to prevent restenosis.
Molécule d'ARN à action catalytique, qui est dirigée contre des molécules d'ARNm codant pour les protéines cycline E ou E2F1 pertinentes pour le cycle cellulaire. Ladite molécule d'ARN à action catalytique est un ribozyme en tête de marteau qui induit l'inhibition du cycle cellulaire de cellules vasculaires de muscles lisses pour prévenir la resténose.
Grassi Gabriele
Kandolf Reinhard
Kuhn Anne
Eberhard-Karls-Universitat Tubingen Universitatsklinikum
Heart Biosystems Gmbh
Sim & Mcburney
LandOfFree
Ribozymes used for restenosis prevention does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ribozymes used for restenosis prevention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribozymes used for restenosis prevention will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1916945